503 Pneumonitis with anti-PD-1/PD-L1 therapy
Naidoo, J, Cunningham, J, Woo, K.M, Hellmann, M.D, Postow, M.A, Drilon, A.E, Chaft, J.E, Lesokhin, A.M, Segal, N.H, Callahan, M.K, Rudin, C.M, Iyriboz, T, Wolchok, J.D
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
29LBA Entrectinib (RXDX-101), an oral pan-Trk, ROS1, and ALK inhibitor in patients with advanced solid tumors harboring gene rearrangements
Siena, S, Drilon, A.E, Sai-Hong Ou, I, Farago, A.F, Patel, M, Bauer, T.M, Hong, D, Liu, S.V, Lee, J, Patel, R, Schechet, L, Luo, D, Chow Maneval, E, Multani, P.S, De Braud, F.G
Published in European journal of cancer (1990) (01.09.2015)
Published in European journal of cancer (1990) (01.09.2015)
Get full text
Journal Article
P2.12-02 Beware: Tyrosine Kinase Inhibitors for Lung Cancers that Inhibit MATE-1 can Lead to "False” Decreases in Renal Function
Chen, M., Harada, G., Liu, D., Dematteo, R., Falcon, C., Wilhelm, C., Kris, M.G., Drilon, A.E.
Published in Journal of thoracic oncology (01.11.2023)
Published in Journal of thoracic oncology (01.11.2023)
Get full text
Journal Article
EP12.02-08 Frequency and Outcomes of Leptomeningeal Metastases in Patients with Fusion-Positive Lung Cancers
Chen, M., Sui, J., Wilcox, J., Yang, S.R., Imber, B., Offin, M., Yu, H., Kris, M.G., Drilon, A.E.
Published in Journal of thoracic oncology (01.11.2023)
Published in Journal of thoracic oncology (01.11.2023)
Get full text
Journal Article
P2.10-06 Brain Metastases in Patients with Fusion-Positive Lung Cancers
Sui, J.S., Chen, M.F., Wilcox, J., Yang, S.R., Li, B.T., Riely, G.J., Offin, M., Yu, H.A., Kris, M.G., Drilon, A.E.
Published in Journal of thoracic oncology (01.11.2023)
Published in Journal of thoracic oncology (01.11.2023)
Get full text
Journal Article
P2.09-14 Clinical Characteristics and Outcomes of Patients with EGFR-mutant Lung Cancer with Acquired BRAF Alterations
Sui, J., Yang, S.R., Bowman, A.S., Vankayala, P., Falcon, C., Somwar, R., Drilon, A.E., Riely, G.J., Kris, M.G., Ladanyi, M., Yu, H.A., Offin, M.
Published in Journal of thoracic oncology (01.11.2023)
Published in Journal of thoracic oncology (01.11.2023)
Get full text
Journal Article
463P Efficacy and safety of larotrectinib in a pooled analysis of patients (Pts) with tropomyosin receptor kinase (TRK) fusion cancer with an extended follow-up
McDermott, R.S., van Tilburg, C., Lin, J.J., Kummar, S., Tan, D.S.W., Albert, C.M., Berlin, J.D., Lassen, U.N., Doz, F., Geoerger, B., Mascarenhas, L., Federman, N., Norenberg, R., Dima, L., Mussi, C., De La Cuesta, E.A., Laetsch, T., Hong, D.S., Drilon, A.E.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1173P Early safety, tolerability, and efficacy of REGN5093 in patients (pts) with MET-altered advanced non-small cell lung cancer (aNSCLC) from a first in human (FIH) study
Cho, B.C., Ahn, M-J., Kim, T.M., Kim, C., Shim, B.Y., Han, J-Y., Drilon, A.E., Lena, H., Gomez, J.E., Gray, J.E., Awad, M., Perez, J., Navas, M., Kaul, M., Patel, S., Gao, B., Magnan, H., Rietschel, P.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1656P Durable efficacy of selpercatinib in patients (pts) with medullary thyroid cancer (MTC): Update of the LIBRETTO-001 trial
Kroiss, M., Sherman, E.J., Wirth, L.J., Cabanillas, M.E., Robinson, B., Subbiah, V., Drilon, A.E., Godbert, Y., Fasnacht, N., Soldatenkova, V., Xia, M.S., Duann, C-W., Wright, J., Weiler-Bisig, D., Shah, M.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
667P Updated efficacy and safety of larotrectinib in patients with TRK fusion salivary gland tumours
Hong, D.S., Tahara, M., Baik, C., Bauman, J.R., Gilbert, J., Brose, M.S., Grilley-Olson, J.E., Patil, T., McDermott, R., Raez, L.E., Johnson, J.M., Shen, L., Norenberg, R., Dima, L., Mussi, C., Le, X., Drilon, A.E.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
980P Continuation of selpercatinib beyond progression in RET fusion-positive NSCLC: Data from LIBRETTO-001 study
Drilon, A.E., Chan, J., Sands, J., Tan, D.S.W., Weiss, J., Solomon, B., Kim, Y.J., Johnson, M.L., Puri, T., Sarno, M.A., Kang, S., Soldatenkova, V., Duann, C-W., Szymczak, S., Subbiah, V., Besse, B.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
P1.22-07 Predictive Biomarkers of Response to REGN5093 to Guide Patient Selection in MET-Altered Advanced Non-small Cell Lung Cancer
Navas, T., Drilon, A.E., Cho, B.C., Viau, J., Tao, W., Zhu, Y.O., Giangreco, N., Perez, J., Masinde, S., Paccaly, A., Krishna, R., Li, Y., Li, S., Daly, C., Patel, S., Laughlin, M., Seebach, F., Pouliot, J.F., Rietschel, P., Magnan, H., Boyapati, A.
Published in Journal of thoracic oncology (01.11.2023)
Published in Journal of thoracic oncology (01.11.2023)
Get full text
Journal Article
464P Intra-patient (Pt) comparison from larotrectinib (Laro) clinical trials in tropomyosin receptor kinase (TRK) fusion cancer: An expanded dataset
Italiano, A., Drilon, A.E., Shen, L., Hong, D.S., van Tilburg, C., Tan, D.S.W., Lin, J.J., Kummar, S., Doz, F., Geoerger, B., Brose, M.S., Briggs, A., Lassen, U.N., Vassal, G., Keating, K.N., Norenberg, R., Dima, L., Brega, N., Laetsch, T., Garcia-Foncillas, J.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1969P - Targeting NRG1-fusions in multiple tumour types: Afatinib as a novel potential treatment option
Liu, S.V., Duruisseaux, M., Tolba, K., Branden, E., Goto, Y., Weinberg, B.A., Renouf, D.J., Doebele, R.C., Heining, C., Schlenk, R.F., Cheema, P.K., Cadranel, J., Jones, M.R., Drilon, A.E., Trombetta, D., Muscarella, L.A., Cseh, A., Solca, F., Laskin, J.J.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Targeting NRG1-fusions in multiple tumour types: Afatinib as a novel potential treatment option
Liu, S.V., Duruisseaux, M., Tolba, K., Branden, E., Goto, Y., Weinberg, B.A., Renouf, D.J., Doebele, R.C., Heining, C., Schlenk, R.F., Cheema, P.K., Cadranel, J., Jones, M.R., Drilon, A.E., Trombetta, D., Muscarella, L.A., Cseh, A., Solca, F., Laskin, J.J.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
A phase 1 study of oral LOXO 292 in adult patients with advanced solid tumors, including RET-fusion non-small cell lung cancer, medullary thyroid cancer and other tumors with increased RET activity
Drilon, A.E., Bauer, T.M., Subbiah, V., Cabanillas, M., Lahkani, N., Wirth, L., Oxnard, G., Smith, S., Eary, T., Cruickshank, S., Nguyen, M., Rothenberg, S.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article
A phase 1b study of RXDX-105, a VEGFR-sparing potent RET inhibitor, in RETi-naïve patients with RET fusion-positive NSCLC
Drilon, A.E., Liu, S., Doebele, R., Rodriguez, C., Fakih, M., Reckamp, K.L., Bazhenova, L., Cho, B.C., Kowack, E., Oliver, J., Multani, P., Ahn, M-J.
Published in Annals of oncology (01.09.2017)
Published in Annals of oncology (01.09.2017)
Get full text
Journal Article